These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 21620077

  • 1. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C, Astegiano S, Terlizzi ME, Sidoti F, Curtoni A, Solidoro P, Baldi S, Bergallo M, Cavallo R.
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic utility of human cytomegalovirus-specific T-cell response monitoring in predicting viremia in pediatric allogeneic stem-cell transplant patients.
    Abate D, Cesaro S, Cofano S, Fiscon M, Saldan A, Varotto S, Mengoli C, Pillon M, Calore E, Biasolo MA, Cusinato R, Barzon L, Messina C, Carli M, Palù G.
    Transplantation; 2012 Mar 15; 93(5):536-42. PubMed ID: 22314338
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A.
    Liver Transpl; 2012 Dec 15; 18(12):1448-55. PubMed ID: 22903934
    [Abstract] [Full Text] [Related]

  • 4. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.
    Puchhammer-Stöckl E, Görzer I, Zoufaly A, Jaksch P, Bauer CC, Klepetko W, Popow-Kraupp T.
    Transplantation; 2006 Jan 27; 81(2):187-94. PubMed ID: 16436961
    [Abstract] [Full Text] [Related]

  • 5. Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.
    Chiereghin A, Gabrielli L, Zanfi C, Petrisli E, Lauro A, Piccirilli G, Baccolini F, Dazzi A, Cescon M, Morelli MC, Pinna AD, Landini MP, Lazzarotto T.
    Transplant Proc; 2010 Jan 27; 42(1):69-73. PubMed ID: 20172283
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival.
    Kerschner H, Jaksch P, Karigl G, Popow-Kraupp T, Klepetko W, Puchhammer-Stöckl E.
    Transplantation; 2009 Jun 15; 87(11):1720-6. PubMed ID: 19502966
    [Abstract] [Full Text] [Related]

  • 7. Herpesviruses detection by quantitative real-time polymerase chain reaction in bronchoalveolar lavage and transbronchial biopsy in lung transplant: viral infections and histopathological correlation.
    Costa C, Delsedime L, Solidoro P, Curtoni A, Bergallo M, Libertucci D, Baldi S, Rinaldi M, Cavallo R.
    Transplant Proc; 2010 May 15; 42(4):1270-4. PubMed ID: 20534278
    [Abstract] [Full Text] [Related]

  • 8. Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.
    Lochmanova A, Lochman I, Tomaskova H, Marsalkova P, Raszka J, Mrazek J, Dedochova J, Martinek A, Brozmanova H, Grundmann M.
    Transplant Proc; 2010 Nov 15; 42(9):3574-7. PubMed ID: 21094818
    [Abstract] [Full Text] [Related]

  • 9. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, Petrisli E, Piccirilli G, Gabrielli L, Grigioni F, Lazzarotto T.
    J Clin Microbiol; 2018 Apr 15; 56(4):. PubMed ID: 29305542
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.
    Abate D, Saldan A, Fiscon M, Cofano S, Paciolla A, Furian L, Ekser B, Biasolo MA, Cusinato R, Mengoli C, Bonfante L, Rossi B, Rigotti P, Sgarabotto D, Barzon L, Palù G.
    J Infect Dis; 2010 Aug 15; 202(4):585-94. PubMed ID: 20594105
    [Abstract] [Full Text] [Related]

  • 11. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY, Ho KN, Yuen KY, Lui SL, Li FK, Chan TM, Lo WK, Cheng IK.
    Clin Transplant; 1997 Aug 15; 11(4):286-93. PubMed ID: 9267717
    [Abstract] [Full Text] [Related]

  • 12. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H, Mutlu E, Köksoy S, Yılmaz VT, Koçak H, Çolak D, Mutlu D, Günseren F, Dinçkan A, Aliosmanoğlu İ, Süleymanlar G, Gültekin M.
    Mikrobiyol Bul; 2016 Apr 15; 50(2):224-35. PubMed ID: 27175495
    [Abstract] [Full Text] [Related]

  • 13. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC.
    J Infect Dis; 2004 Sep 15; 190(6):1076-83. PubMed ID: 15319856
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.
    Schlischewsky E, Fuehner T, Warnecke G, Welte T, Haverich A, Ganzenmueller T, Heim A, Gottlieb J.
    Transpl Infect Dis; 2013 Feb 15; 15(1):60-9. PubMed ID: 23025532
    [Abstract] [Full Text] [Related]

  • 15. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
    Nickel P, Bold G, Presber F, Biti D, Babel N, Kreutzer S, Pratschke J, Schönemann C, Kern F, Volk HD, Reinke P.
    Transpl Immunol; 2009 Mar 15; 20(4):238-42. PubMed ID: 19032982
    [Abstract] [Full Text] [Related]

  • 16. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.
    Wiita AP, Roubinian N, Khan Y, Chin-Hong PV, Singer JP, Golden JA, Miller S.
    Transpl Infect Dis; 2012 Jun 15; 14(3):248-58. PubMed ID: 22385394
    [Abstract] [Full Text] [Related]

  • 17. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, Valantine HA, Mocarski ES, Lewis DB.
    Circulation; 2006 Oct 10; 114(15):1608-15. PubMed ID: 17015794
    [Abstract] [Full Text] [Related]

  • 18. Tailored combined cytomegalovirus management in lung transplantation: a retrospective analysis.
    Solidoro P, Patrucco F, Libertucci D, Verri G, Sidoti F, Curtoni A, Boffini M, Simonato E, Rinaldi M, Cavallo R, Costa C.
    Ther Adv Respir Dis; 2019 Oct 10; 13():1753466619878555. PubMed ID: 31566097
    [No Abstract] [Full Text] [Related]

  • 19. Early diagnosis and effective treatment of pulmonary CMV infection after lung transplantation.
    Steinhoff G, Behrend M, Wagner TO, Höper MH, Haverich A.
    J Heart Lung Transplant; 1991 Oct 10; 10(1 Pt 1):9-14. PubMed ID: 1848789
    [Abstract] [Full Text] [Related]

  • 20. The lack of cytomegalovirus-specific cellular immune response may contribute to the onset of organ infection and disease in lung transplant recipients.
    Costa C, Saldan A, Sinesi F, Sidoti F, Balloco C, Simeone S, Piceghello A, Mantovani S, Di Nauta A, Solidoro P, Cavallo R.
    Int J Immunopathol Pharmacol; 2012 Oct 10; 25(4):1003-9. PubMed ID: 23298490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.